Targets, Tracers and Translation - Novel Radiopharmaceuticals Boost Nuclear Medicine

This is the fourth Special Issue in Pharmaceuticals within the last six years dealing with aspects of radiopharmaceutical sciences. It demonstrates the significant interest and increasing relevance to ameliorate nuclear medicine imaging with PET or SPECT, and also radiotherapeutical procedures.Numer...

Full description

Saved in:
Bibliographic Details
Main Author: Reischl, Gerald (auth)
Format: Electronic Book Chapter
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2019
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_60492
005 20210212
003 oapen
006 m o d
007 cr|mn|---annan
008 20210212s2019 xx |||||o ||| 0|eng d
020 |a books978-3-03921-314-6 
020 |a 9783039213139 
020 |a 9783039213146 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-03921-314-6  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Reischl, Gerald  |4 auth 
245 1 0 |a Targets, Tracers and Translation - Novel Radiopharmaceuticals Boost Nuclear Medicine 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2019 
300 |a 1 electronic resource (214 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a This is the fourth Special Issue in Pharmaceuticals within the last six years dealing with aspects of radiopharmaceutical sciences. It demonstrates the significant interest and increasing relevance to ameliorate nuclear medicine imaging with PET or SPECT, and also radiotherapeutical procedures.Numerous targets and mechanisms have been identified and have been under investigation over the previous years, covering many fields of medical and clinical research. This development is well illustrated by the articles in the present issue, including 13 original research papers and one review, covering a broad range of actual research topics in the field of radiopharmaceutical sciences. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a n/a 
653 |a pretargeting 
653 |a radioiodination 
653 |a neurodegeneration 
653 |a phosphoramidon 
653 |a GRPR 
653 |a molecular imaging 
653 |a allosteric modulator 
653 |a radiosynthesis 
653 |a separation 
653 |a ?-CIT. 
653 |a PET/CT imaging 
653 |a technetium-99m 
653 |a gastrin-releasing peptide receptor 
653 |a metabotropic glutamate receptor subtype 5 
653 |a glutamate 
653 |a oncogenic fusions 
653 |a Fusarinine C 
653 |a hypoxia 
653 |a tirapazamine (TPZ) 
653 |a 68Ga 
653 |a sentinel lymph node 
653 |a 99mTc-radioligand 
653 |a iodine-131 
653 |a electrophilic radioiodination 
653 |a 4-dioxide (BTDO) 
653 |a minigastrin 
653 |a ceftriaxone 
653 |a tropomyosin receptor kinase 
653 |a carbonic anhydrase IX 
653 |a ABP688 
653 |a NPY(Y1)R 
653 |a MMPEP 
653 |a radiosensitizer 
653 |a neprilysin-inhibition 
653 |a radiochemistry 
653 |a girentuximab 
653 |a benzotriazine-1 
653 |a gallium-68 
653 |a cholecystokinin-2 receptor 
653 |a tumor targeting 
653 |a radioimmunotherapy 
653 |a salivary gland uptake 
653 |a metabolic stability 
653 |a tumor hypoxia 
653 |a multimerization 
653 |a oxidizing agent 
653 |a neuroinflammation 
653 |a gastrin-releasing peptide 
653 |a dextran 
653 |a carbon-11 
653 |a peptide heterodimers 
653 |a apparent molar activity 
653 |a radiometals 
653 |a microglia 
653 |a rituximab 
653 |a [18F]FMISO 
653 |a [11C]meta-hydroxyephedrine 
653 |a Iodo-Gen® 
653 |a mannose 
653 |a 177Lu-radiopharmaceuticals 
653 |a azomycin nucleosides 
653 |a breast cancer 
653 |a click chemistry 
653 |a small animal imaging 
653 |a SR 4317 
653 |a benzotriazine-1-monoxide (BTMO) 
653 |a bombesin 
653 |a prostate cancer 
653 |a Chloramine T 
653 |a 99mTc-radiopharmaceuticals 
653 |a ketamine 
653 |a PSMA-617 
653 |a positron emission tomography 
653 |a hydrazinonicotinic acid (HYNIC) 
653 |a renal cell carcinomas 
653 |a [18F]PSS232 
653 |a PET 
653 |a endoradiotherapy 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/1555  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/60492  |7 0  |z DOAB: description of the publication